Cargando…

Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. HCC cells possess biological characteristics of high invasion and metastasis. In this respect, to prevent cancer cell invasion and metastasis and early active intervention, we herein screened through the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jia-Ning, Wei, Feng, Lei, Lin-Han, Yang, Yang, Yang, Yuan, Zhou, Wei-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810199/ https://www.ncbi.nlm.nih.gov/pubmed/34784846 http://dx.doi.org/10.1080/21655979.2021.2006942

Ejemplares similares

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2019)

Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
por: Wei, Zhong-liu, et al.
Publicado: (2022)

Therapeutic targeting of transcriptional cyclin-dependent kinases
por: Galbraith, Matthew D., et al.
Publicado: (2018)

Coupling function of cyclin‐dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma
por: Xu, Chenzhou, et al.
Publicado: (2018)

Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Identification of Biological Targets of Therapeutic Intervention for Hepatocellular Carcinoma by Integrated Bioinformatical Analysis
por: Hu, Wei Qi, et al.
Publicado: (2018)

Expression and prognostic value of transcription-associated cyclin-dependent kinases in human breast cancer
por: Li, Ning, et al.
Publicado: (2021)

Verification of cell cycle-associated cyclin-dependent kinases facilitated prostate cancer progression by integrated bioinformatic analysis and experimental validation
por: Huang, Yean, et al.
Publicado: (2022)

Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth
por: LIN, WEY-RAN, et al.
Publicado: (2012)

The effect of R547, a cyclin-dependent kinase inhibitor, on hepatocellular carcinoma cell death
por: HACIOĞLU*, Betül, et al.
Publicado: (2020)

Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
por: Thoma, Oana-Maria, et al.
Publicado: (2021)

Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer
por: Constantin, Theodora A., et al.
Publicado: (2022)

Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics
por: Yousuf, Mohd, et al.
Publicado: (2022)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
por: Beck, Halfdan, et al.
Publicado: (2010)

Requirement for A-type cyclin-dependent kinase and cyclins for the terminal division in the stomatal lineage of Arabidopsis
por: Yang, Kezhen, et al.
Publicado: (2014)

Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2021)

Cyclin-Dependent Kinase Inhibitor 2A/B Homozygous Deletion Prediction and Survival Analysis
por: Yang, Jing, et al.
Publicado: (2023)

Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers
por: Lin, Z. Ping, et al.
Publicado: (2018)

Cyclin-dependent kinases in C. elegans
por: Boxem, Mike
Publicado: (2006)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy
por: Ardelt, Maximilian A., et al.
Publicado: (2018)

The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells
por: Zocchi, Loredana, et al.
Publicado: (2018)

Cyclin Y Modulates the Proliferation, Invasion, and Metastasis of Hepatocellular Carcinoma Cells
por: Shi, Kaishun, et al.
Publicado: (2018)

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma
por: Greenall, S A, et al.
Publicado: (2017)

Cyclin-Dependent Kinase and Antioxidant Gene Expression in Cancers with Poor Therapeutic Response
por: Scaria, George S., et al.
Publicado: (2020)

The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
por: Ding, Lei, et al.
Publicado: (2020)

Integrated Bioinformatics Analysis and Validation of the Prognostic Value of RBM10 Expression in Hepatocellular Carcinoma
por: Pang, Shu-Jie, et al.
Publicado: (2022)

Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression
por: Yang, Liu, et al.
Publicado: (2015)

Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma
por: Wang, Jia, et al.
Publicado: (2016)

Prediction of Cyclin-Dependent Kinase Phosphorylation Substrates
por: Chang, Emmanuel J., et al.
Publicado: (2007)

Cyclin-dependent kinase control of motile ciliogenesis
por: Vladar, Eszter K, et al.
Publicado: (2018)

Cyclin-dependent kinases and rare developmental disorders
por: Colas, Pierre
Publicado: (2020)

Cyclin-dependent kinase inhibitors in malignant hematopoiesis
por: Schirripa, Alessia, et al.
Publicado: (2022)

Targeting cyclin-dependent kinase 4/6 as a therapeutic approach for mucosal melanoma
por: Shi, Chao-ji, et al.
Publicado: (2021)

Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase
por: Rana, Sandeep, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2gk09apd5nimhkaviep75dni78